| Activity of the uptake-1 norepinephrine transporter as measured by I-123 MIBG in heart failure patients with a loss-of-function polymorphism of the presynaptic alpha2C-adrenergic receptor. | |
| | |
MedLine Citation:
|
PMID: 14668769 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Patients with a deletion of 4 consecutive amino acids in the gene encoding for the alpha(2C)-adrenergic receptor (alpha(2C)Del322-325) have an increased prevalence of clinical heart failure, worse clinical status, and a lower left ventricular ejection fraction compared with patients without this deletion. We postulated that patients with the alpha(2C)Del322-325 polymorphism would have a compensatory increase in norepinephrine uptake-1 transporter activity as measured by iodine 123 metaiodobenzylguanidine (MIBG). METHODS AND RESULTS: Thirty-nine patients with heart failure related to idiopathic dilated cardiomyopathy were studied. Demographic characteristics, left ventricular ejection fraction, maximum oxygen consumption, exercise duration, and plasma norepinephrine levels did not differ between patients with the alpha(2C) receptor polymorphism (n = 9) and those without it (n = 30). Patients with the alpha(2C)Del322-325 polymorphism had significantly greater heart-to-mediastinum ratios of I-123 MIBG at 4 hours after tracer injection (1.60 +/- 0.19 vs 1.41 +/- 0.19, P =.0117) and greater background-corrected heart counts per pixel at 4 hours compared with patients without the polymorphism. CONCLUSIONS: Patients with genetic impairment of the alpha(2C)-adrenergic receptor have augmented activity of the norepinephrine uptake-1 transporter as measured by I-123 MIBG. Further studies are needed to clarify the mechanism by which uptake-1 transporter activity is increased in this setting. |
| | |
Authors:
|
Myron C Gerson; Lynne E Wagoner; Nancy McGuire; Stephen B Liggett |
Related Documents
:
|
9379189 - Effects of cilazapril and verapamil on myocardial iodine-125-metaiodobenzylguanidine ac... 20067509 - Autonomic alterations and cardiac changes in epilepsy. 7691289 - Cardiac dysrhythmias during cardiovascular autonomic reflex tests. 19403339 - Symbolic analysis detects alterations of cardiac autonomic modulation in congestive hea... 20410249 - Prolonged cardiac effects of momentary assessed stressful events and worry episodes. 15870589 - Heart rate variability analysis in the assessment of autonomic function in heart failure. 8506189 - Histopathological examination of specimens removed during directional coronary atherect... 19198609 - Genome-wide association of early-onset myocardial infarction with single nucleotide pol... 23657019 - Anaemia in congestive heart failure. |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology Volume: 10 ISSN: 1071-3581 ISO Abbreviation: J Nucl Cardiol Publication Date: 2003 Nov-Dec |
Date Detail:
|
Created Date: 2003-12-11 Completed Date: 2004-05-04 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 9423534 Medline TA: J Nucl Cardiol Country: United States |
Other Details:
|
Languages: eng Pagination: 583-9 Citation Subset: IM |
Affiliation:
|
Division of Cardiology, University of Cincinnati, Ohio 45267-0542, USA. myron.gerson@uc.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
3-Iodobenzylguanidine
/
diagnostic use* Cardiac Output, Low / complications, metabolism*, radionuclide imaging* Cardiomyopathy, Dilated / complications, metabolism*, radionuclide imaging* Female Gene Deletion Genetic Predisposition to Disease / genetics Heart / innervation, radionuclide imaging Heart Failure / complications, metabolism, radionuclide imaging Humans Male Middle Aged Mutation Norepinephrine Plasma Membrane Transport Proteins Polymorphism, Genetic / genetics Radiopharmaceuticals / diagnostic use Receptors, Adrenergic, alpha-2 / deficiency, genetics* Sympathetic Nervous System / radionuclide imaging Symporters / genetics*, metabolism* Ventricular Dysfunction, Left / metabolism*, radionuclide imaging* |
| Chemical | |
Reg. No./Substance:
|
0/Norepinephrine Plasma Membrane Transport Proteins; 0/Radiopharmaceuticals; 0/Receptors, Adrenergic, alpha-2; 0/SLC6A2 protein, human; 0/Symporters; 0/adrenergic receptor alpha(2C); 77679-27-7/3-Iodobenzylguanidine |
| Comments/Corrections | |
Comment In:
|
J Nucl Cardiol. 2003 Nov-Dec;10(6):700-4
[PMID:
14668785
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Anterior deprogramming device fabrication using a thermoplastic material.
Next Document: Coronary calcium screening in asymptomatic patients as a guide to risk factor modification and stres...